<?xml version="1.0" encoding="UTF-8"?>
<p id="Par956">
 <bold>Conclusions:</bold> In refractory shock patients with sepsis, the values of C1INH were low (especially in non survivors) at admission and day 1. The validity of C1INH replacement therapy in patients with septic shock may lead to a new strategy for management in sepsis.
</p>
